Kardigan Shares Soar 38% on Nasdaq Debut After $400M Upsized IPO
Summary
Kardigan's stock surged 38% in its Nasdaq trading debut, following an upsized initial public offering that raised $400 million. This strong first-day performance significantly exceeds earlier reports of a modest gain. The heart-health biotech priced 25 million shares at $16.00 each, indicating robust investor demand for the new issue.
At the time of this announcement, KARD was trading at $22.00 on NASDAQ in the Life Sciences sector. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Binance News.